Pages that link to "Q38159121"
Jump to navigation
Jump to search
The following pages link to Harnessing the benefits of PPARβ/δ agonists. (Q38159121):
Displaying 10 items.
- GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes (Q34041838) (← links)
- Activation of PPARδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction. (Q36000038) (← links)
- PPAR-pan activation induces hepatic oxidative stress and lipidomic remodelling (Q36962706) (← links)
- Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future (Q38641190) (← links)
- Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation. (Q39018398) (← links)
- PPARs and nonalcoholic fatty liver disease (Q39029023) (← links)
- Review. The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease (Q39148023) (← links)
- Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia (Q42270680) (← links)
- PPARα Agonist Suppresses Inflammation after Corneal Alkali Burn by Suppressing Proinflammatory Cytokines, MCP-1, and Nuclear Translocation of NF-κB (Q61453965) (← links)
- Proteomics study of the effect of high-fat diet on rat liver (Q91933445) (← links)